PaySign Inc(PAYS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 55.92 | EPS (ttm) | 0.26 | Insider Own | 27.32% | Shs Outstand | 56.4M | Perf Week | -0.14% |
| Market Cap | 0.81B | Forward P/E | 33.69 | EPS next Y | 23.19% | Insider Trans | -4.7% | Shs Float | 41.0M | Perf Month | -4.21% |
| Enterprise Value | 0.64B | PEG | 0.58 | EPS next Q | 0.09 | Inst Own | 54.61% | Short Float | 6.11% | Perf Quarter | 14.74% |
| Income | 0.02B | P/S | 8.03 | EPS this Y | 165.38% | Inst Trans | 13.94% | Short Ratio | 2.95 | Perf Half Y | 113.41% |
| Sales | 0.10B | P/B | 13.44 | EPS next 5Y | 57.72% | ROA | 6.17% | Short Interest | 2.51M | Perf YTD | 178.06% |
| Book/sh | 1.07 | P/C | 4.58 | EPS past 3/5Y | 86.87% - | ROE | 30.82% | 52W High | -11.36% ($16.15) | Perf Year | 174.07% |
| Cash/sh | 3.13 | P/FCF | 11.88 | Sales past 3/5Y | 29.2% 27.74% | ROIC | 24.28% | 52W Low | 364.94% ($3.08) | Perf 3Y | 625.06% |
| Dividend Est. | - | EV/EBITDA | 24.08 | EPS Y/Y TTM | 125.24% | Gross Margin | 51.68% | Volatility(W/M) | 7.78% 6.04% | Perf 5Y | 461.57% |
| Dividend TTM | - | EV/Sales | 6.34 | Sales Y/Y TTM | 46.84% | Oper. Margin | 17.01% | ATR (14) | 0.9 | Perf 10Y | 8323.53% |
| Dividend Ex-Date | - | Quick Ratio | 1.14 | EPS Q/Q | 354.17% | Profit Margin | 15.67% | RSI (14) | 48.84 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.14 | Sales Q/Q | 48.08% | SMA20 | -3.91% ($14.9) | Beta | 0.87 | Target Price | $14.1 |
| Payout | - | Debt/Eq | 0.09 | Earnings | 2026/11/9 | SMA50 | 3.42% ($13.85) | Rel Volume | 1.2 | Prev Close | $15.3 |
| Employees | 226 | LT Debt/Eq | 0.08 | EPS/Sales Surpr. | 83.33% 7.18% | SMA200 | 67.75% ($8.54) | Avg Volume(3M) | 0.85M | Price | $14.32 |
| IPO | 2003/10/27 | Option/Short | Yes/Yes | Trades | 7897 | Volume | 1,025,460 | Change | -6.41% |
💳 Paysign is a U.S. fintech company that operates prepaid card programs and pharmaceutical patient affordability solutions. Through an integrated payment platform encompassing prepaid and debit card issuance, payment processing, and digital banking, the company provides payment infrastructure to specialized markets such as pharmaceuticals and plasma donation centers.
Over the past 1 year, on the higher side
11% below its 1-year high.
Traded about as much as usual. That is 120% of its average volume.
Next earnings report: November 9
3 days to go.
PAYS makes money exceptionally well
Of every $100 in sales, $17.01 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +165.4% this year.
Tap to view numbers
However, it looks expensive
For a company earning $100 a year, you would pay $5,592. Peers typically go for $1,780. Compared with its own 4-year average, it is 39% pricier now.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +461.6%. The S&P 500 did +56% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 54.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #84 of 181 in the industry
Based on market cap of $809M.
FAQ
What kind of company is PAYS?
PAYS belongs to the Technology sector and operates in the Software - Infrastructure industry.
What is the market cap of PAYS?
The market cap of PAYS is approximately $809M, ranking 2,726 within its sector.
What is the P/E ratio of PAYS?
PAYS has a P/E ratio of approximately 55.9x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for PAYS?
PAYS has recorded a 52-week high of $16.15 and a low of $3.08.